Genotyping of p53 codon 175 in colorectal cancer

Medical Science Monitor

Volumn 9, Issue 5, 2003, Pages

  Krajewska, Wanda M ^a   Stawińska, Magdalena ^a   Bryś, Magdalena ^a   Młynarski, Wojciech ^b   Witas, Henryk ^b   Okruszek, Andrzej ^c   Kiliańska, Zofia M ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c CENTRE OF MOLECULAR AND MACROMOLECULAR STUDIES   (Poland)

Author keywords

ASA PCR; Colorectal cancer progression; G A transition; Tumor suppressor protein

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CODON; COLORECTAL CANCER; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AMINO ACID SUBSTITUTION; BASE SEQUENCE; CODON; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; GENES, P53; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0038171184     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ko LJ, Privies C: p53: puzzle and paradigm. Genes Dev, 1996; 10: 1054-72
2. Wiesmüller L. The tumor suppressor p53 in the center of a strategy aiming at the alleviation of side effects in cancer therapies. Angew Chem Int E, 2000; 39: 1768-70
3. Ryau KM, Philips AC, Vousden KH: Regulation and function of the p53 tumor suppressor protein. Current Opinion in Cell Biology, 2000; 13: 332-7
4. Béroud A, Verdier F, Soussi T: p 53 gene mutation: software and database. Nucl Acids Res, 1996; 24: 147-50
5. Hollstein M, Shomer B, Greenblatt M et al: Somatic points mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucl Acids Res, 1996; 24: 141-6
6. Béroud A, Soussi T: p53 and APC gene mutation: software and database. Nucl Acids Res, 1997; 25: 138
7. Béroud A, Soussi T: p53 gene mutation: software and database. Nucl Acids Res, 1998; 26: 200-4
8. Hainaut P, Soussi T, Shomer B et al: Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucl Acids Res, 1997; 25: 151-7
9. Hussain SP, Harris C: Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res, 1998; 58: 4023-37
10. Hussain SP, Harris C: Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens. Mutation Research, 2000; 462: 311-22
11. Cadwell C, Zambetti GP: The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function of cell growth. Gene, 2001; 277: 15-30
12. Smith DR, Ji CY, Goh HS: Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer, 1996; 74: 216-23
13. Goh HS, Yao J, Smith DR: p53 point mutation and survival in colorectal cancer patients. Cancer Res, 1995; 55: 5217-21
14. Dukes CE: The classification of cancer of the rectum. J Path Bact, 1932; 35: 323-32
15. Rolfs A, Schleer I, Fink U, Weber-Roif I: PCR: Clinical diagnostics and research. Springer Lab Press, 1993; 81-4
16. Dutton C, Sommer SS: Simultaneous detection of multiples singlebase alleles at a polymorphic site. Biotechniques, 1989; 11: 700-2
17. Farr C, Saiki RK: Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probe. Proc Natl Acad Sci USA, 1988; 85: 1629-33
18. Shaw P, Tardy S, Benito E et al: Occurrence of Ki-ras and p53 mutations in primary colorectal tumors. Oncogene, 1991; 6: 2121-8
19. Kikuchi-Yanoshita T, Konishi M, Ito S et al: Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res, 1992; 52: 3965-71
20. Kastrinakis WV, Ramchurren N, Rieger KM et al: Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene, 1995; 11: 647-52
21. Slebos RJC, Baas IO, Clement M et al: Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma. Br J Cancer, 1996; 74: 165-71
22. Soussi T: The p53 tumour suppressor gene: a model for molecular epidemiology of human cancer. Mol Med Today, 1996; 2: 32-7
23. Pauly M, Schmitz M, Kayser I et al: Ki-ras oncogene and p53 tumour suppressor gene mutations in colorectal carcinomas from the European Saar-Luxembourg region are less frequent than predicted by the classic adenoma-carcinoma sequence model. Eur J Cancer, 1997; 33: 2265-72
24. Goh HS, Smith DR: p53 point mutation and survival in colorectal cancer patients: effect of disease dissemination and tumour location. Int J Oncol, 1999; 15: 491-8
25. Jansson A, Gentile M, Sun XF: p53 mutations are present in colorectal cancer with cytoplasmic p53 accumulation. Int J Cancer, 2001; 92: 338-41
26. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67
27. Ohue M, Tomita N, Monden T et al: A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer Res, 1994; 54: 4798-804
28. Hasegawa H, Ueda M, Furukawa K et al: p53 gene mutations in early colorectal carcinoma. De novo vs. adenoma-carcinoma sequence. Int J Cancer, 1995; 64: 47-51
29. Lashner BA, Shapiro BD, Husain A, Goldblum JR: Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis. Am J Gastroenterol, 1999; 94: 456-62
30. McLeod HL, Murray GI: Tumour markers of prognosis in colorectal cancer. Br J Cancer, 1999; 79: 191-203
31. Bouzourene H, Gervaz P, Cerottini JP et al: p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer. Eur J Cancer, 2000; 36: 1008-15
32. Stawińska M, Bryś M, Kiliańska ZM et al: Cellular protein alterations in colorectal cancer: p28, p53 and p65 studies. Cytobios, 2001; 106: 43-55